SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: tewdwr who wrote (950)6/13/1999 7:49:00 PM
From: SG  Respond to of 965
 
Many thanks; actually my teenage son with Crohn's- real bad illness.

Stock tip for you--most people with severe Crohn's need repeat infusions; FDA will probably approve multiple reinfusions that have been requested from them. At $2000/infusion imagine what this will add to CNTO's bottom line over time.

Thanks.

SG